GlassScriptPhysician profile
Imdad Ahmed
NPI 1053536219
$164,091.97
in general payments reported to CMS, 2019-2025
24 companies · $37K in 2025
The $37K reported for 2025 was more than what 98% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $19K · 2020: $6,176 · 2021: $19K · 2022: $14K · 2023: $18K · 2024: $51K · 2025: $37K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $50K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $35K · Food and Beverage: $12K · Travel and Lodging: $10K.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $49,631.97 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $34,750.00 |
| Food and Beverage | $11,563.39 |
| Travel and Lodging | $10,161.27 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medical Device Business Services, INC. | $58,367.61 | 2019-2025 | Carto 3 |
| Biosense Webster, INC. | $37,485.55 | 2019-2025 | Carto 3, Qdot Micro Catheter, Nuvision Ice Catheter |
| Boston Scientific Corporation | $31,833.67 | 2019-2025 | Watchman Access System, Watchman, Watchman Flx |
| Abbott Laboratories | $14,042.22 | 2019-2025 | Aveir, Accent, Allure |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $9,027.46 | 2023-2025 | Lifevest |
| Medtronic Vascular, INC. | $3,897.34 | 2019 | |
| Biotronik INC. | $2,998.29 | 2025 | |
| Medtronic, INC. | $2,864.56 | 2022-2025 | Evera Mri Xt Dr Surescan, Linq II, Cobalt Dr Mri Surescan |
| Altathera Pharmaceuticals LLC | $1,165.68 | 2024-2025 | Sotalol Hydrochloride |
| Philips North America LLC | $919.43 | 2019-2025 | (9520) Igt Devices Undivided, Igt Devices Undivided |
| Cardiva Medical, INC. | $577.83 | 2022-2023 | Cardiva Vascade Mvp Vvcs 6-12f |
| Elutia, INC. | $245.09 | 2022-2025 | Ecm Patch,Pouch |
| Volta Medical INC | $210.38 | 2025 | Vx1 |
| Atricure, INC. | $130.60 | 2022 | |
| Kestra Medical Technology Services, INC. | $63.45 | 2023 | Assure Wcd |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Edwards Lifesciences Corporation | $56.43 | 2024 | Hemosphere |
| Sanofi-Aventis U.S. LLC | $41.42 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $40.47 | 2019 | |
| Lundbeck LLC | $40.34 | 2019 | |
| Livanova USA, INC. | $25.98 | 2022 | |
| Cardiovascular Systems INC. | $17.45 | 2019 | |
| Novartis Pharmaceuticals Corporation | $14.15 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $13.89 | 2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $12.68 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Imdad Ahmed listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.